We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a dramatic reversal, new Brazilian Health Minister Saraiva Felipe has said
that no agreement has been signed with US drugmaker Abbott over its HIV/AIDS
drug Kaletra, and that negotiations would continue.
Despite accession to the European Union (EU) in May 2004, a number of new
member states, such as Slovenia, continue to infringe pharmaceutical patents.
The Honourable Minister for Science and Technology, Professor Turner Isoun has
admonished Nigerians to invest in Xechem Pharmaceuticals Nigeria Limited.
Chugai Pharmaceutical Co. (4519.TO) said Thursday its group net profit more
than doubled in the six months ended in June, lifted by strong sales of its
influenza remedy and cost reductions.
Takeda Pharmaceutical Company Limited and PPD, Inc. (Nasdaq: PPDI - News) today
announced an agreement in which Takeda acquired the development and marketing
rights to all dipeptidyl peptidase IV (DPP4) inhibitors previously granted to
PPD under an agreement between PPD and Syrrx, Inc.
OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) announced today that Health Canada has
approved Tarceva(R) (erlotinib) for the treatment of patients with locally advanced
or metastatic non-small cell lung cancer (NSCLC), following failure of first
or second-line chemotherapy.
MIGENIX Inc., a clinical-stage developer of drugs for infectious and degenerative
diseases, has completed a Material Transfer and License Option Agreement ("Agreement")
with Schering-Plough Corporation of Kenilworth, N.J., related to celgosivir
(MX-3253), MIGENIX's first-in- class compound in Phase II clinical development
for the treatment of chronic Hepatitis C Virus (HCV) infections.